Skip to content

Contact +44 (0) 20 7060 7474 email us

Medical Devices

China Orthopedic Devices Medical Equipment Industry Report

Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Joint Reconstruction, Spinal Surgery, Trauma Fixation, Orthobiologics, Diagnostic Devices, Equipment and Supplies

Publication Date April 2008
Publisher Global Markets Direct
Product Type Report
Pages 496
ISBN Number not applicable
Product Code GMD00433

Price

£1,980.00
approximately: $2,998 | €2,210

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

China Orthopedic Devices Medical Equipment Industry Report

Summary

This report is an essential source for in-depth information and data relating to China Orthopedic Device market Broken Down to Categories, Segments. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key segments of the Orthopedic Devices Market in China.

Scope

  • The report provides sector information broken down into detailed categories and segments in the region.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the industry at country level
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 Table Of Contents
    • 1.1 List Of 1.2 List Of 2 Introduction
    • 2.1 What Is This Report About?
    • 2.2 Definitions
      • 2.2.1 Orthopedic Devices
  • 3 Healthcare Sector Review
    • 3.1 Healthcare Expenditure
    • 3.2 Healthcare Infrastructure
      • 3.2.1 Healthcare Personnel Data
      • 3.2.2 Healthcare Facilities Data
    • 3.3 Healthcare Policy
  • 4 Orthopedic Devices in China
    • 4.1 Orthopedic Devices Overall Revenues (2000-2012)
    • 4.2 Orthopedic Devices Overall Volume (2000-2012)
    • 4.3 Orthopedic Devices Overall Company Share (2005-2006)
  • 5 Joint Reconstruction in China
    • 5.1 Joint Reconstruction Overall Revenue (2000-2012)
      • 5.1.1 Hip Replacement Overall Revenue (2000-2012)
      • 5.1.2 Knee Replacement Overall Revenue (2000-2012)
      • 5.1.3 Shoulder Replacement Overall Revenue (2000-2012)
      • 5.1.4 Digits Replacement Overall Revenue (2000-2012)
      • 5.1.5 Elbow Replacement Overall Revenue (2000-2012)
      • 5.1.6 Ankle Replacement Overall Revenue (2000-2012)
      • 5.1.7 Wrist Replacement Overall Revenue (2000-2012)
    • 5.2 Joint Reconstruction Overall Volume (2000-2012)
      • 5.2.1 Hip Replacement Overall Volume (2000-2012)
      • 5.2.2 Knee Replacement Overall Volume (2000-2012)
      • 5.2.3 Shoulder Replacement Overall Volume (2000-2012)
      • 5.2.4 Digits Replacement Overall Volume (2000-2012)
      • 5.2.5 Elbow Replacement Overall Volume (2000-2012)
      • 5.2.6 Ankle Replacement Overall Volume (2000-2012)
      • 5.2.7 Wrist Replacement Overall Volume (2000-2012)
    • 5.3 Joint Reconstruction Average Price (2000-2012)
      • 5.3.1 Ankle Replacement Average Price (2000-2012)
      • 5.3.2 Wrist Replacement Average Price (2000-2012)
      • 5.3.3 Knee Replacement Average Price (2000-2012)
      • 5.3.4 Hip Replacement Average Price (2000-2012)
      • 5.3.5 Shoulder Replacement Average Price (2000-2012)
      • 5.3.6 Digits Replacement Average Price (2000-2012)
    • 5.4 Joint Reconstruction Distribution Share (2005-2006)
    • 5.5 Joint Reconstruction Company Share (2005-2006)
  • 6 Orthobiologics in China
    • 6.1 Orthobiologics Overall Revenues (2000-2012)
      • 6.1.1 Bone Graft Substitutes Overall Revenues (2000-2012)
      • 6.1.2 Bone Growth and Spinal Stimulation Overall Revenues (2000-2012)
      • 6.1.3 Viscosupplementation Overall Revenues (2000-2012)
      • 6.1.4 DBM overall Revenues (2000-2012)
      • 6.1.5 Bone Allografts Overall Revenues (2000-2012)
    • 6.2 Orthobiologics Overall Volume (2000-2012)
      • 6.2.1 Bone Graft Substitutes Overall Volume (2000-2012)
      • 6.2.2 Viscosupplementation Overall Volume (2000-2012)
      • 6.2.3 Bone Growth and Spinal Stimulation (2000-2012)
      • 6.2.4 Bone Allografts Overall Volume (2000-2012)
      • 6.2.5 DBM Overall Volume (2000-2012)
    • 6.3 Orthobiologics Average Price (2000-2012)
      • 6.3.1 Bone Graft Substitute Average Price (2000-2012)
      • 6.3.2 Bone Allografts Average Price (2000-2012)
      • 6.3.3 DBM Average Price (2000-2012)
      • 6.3.4 Bone Growth and Spinal Stimulation Average Price (2000-2012)
      • 6.3.5 Viscosupplementation Average Price (2000-2012)
    • 6.4 Orthobiologics Distribution Share (2005-2006)
    • 6.5 Orthobiologics Company Share (2005-2006)
  • 7 Orthopedic Braces and Supports in China
    • 7.1 Orthopedic Braces and Supports Overall Revenues (2000-2012)
      • 7.1.1 Knee Braces and Supports Overall Revenues (2000-2012)
      • 7.1.2 Ankle Braces and Supports Overall Revenues (2000-2012)
      • 7.1.3 Wrist and Others Overall Revenues (2000-2012)
    • 7.2 Orthopedic Braces and Supports Overall Volume (2000-2012)
      • 7.2.1 Knee Braces and Supports Overall Volume (2000-2012)
      • 7.2.2 Ankle Braces and Supports Overall Volume (2000-2012)
      • 7.2.3 Wrist and Others Overall Volume (2000-2012)
    • 7.3 Orthopedic Braces and Supports Average Price (2000-2012)
      • 7.3.1 Knee Braces and Supports Average Price (2000-2012)
      • 7.3.2 Ankle Braces and Supports Average Price (2000-2012)
      • 7.3.3 Wrist and Others Average Price (2000-2012)
    • 7.4 Orthopedic Braces and Supports Distribution Share (2005-2006)
    • 7.5 Orthopedic Braces and Supports Company Share
  • 8 Spinal Surgery in China
    • 8.1 Spinal Surgery Overall Revenues (2000-2012)
      • 8.1.1 Fusion Overall Revenues (2000-2012)
      • 8.1.2 Non-Fusion Overall Revenues (2000-2012)
    • 8.2 Spinal Surgery Overall Volume (2000-2012)
      • 8.2.1 Fusion Overall Volume (2000-2012)
      • 8.2.2 Non-Fusion Overall Volume (2000-2012)
    • 8.3 Spinal Surgery Average Price (2000-2012)
      • 8.3.1 Fusion Average Price (2000-2012)
      • 8.3.2 Non-Fusion Average Price (2000-2012)
    • 8.4 Spinal Surgery Distribution Share (2005-2006)
    • 8.5 Spinal Surgery Company Share (2005-2006)
  • 9 Orthopedic Diagnostic Devices in China
    • 9.1 Orthopedic Diagnostic Devices Overall Revenues (2000-2012)
    • 9.2 Orthopedic Diagnostic Devices Overall Volume (2000-2012)
    • 9.3 Orthopedic Diagnostic Devices Average Price (2000-2012)
    • 9.4 Orthopedic Diagnostic Devices Distribution Share (2005-2006)
    • 9.5 Orthopedic Diagnostic Devices Company Share (2005-2006)
  • 10 Trauma Fixation in China
    • 10.1 Trauma Fixation Overall Revenues (2000-2012)
      • 10.1.1 Internal Fixators Overall Revenues (2000-2012)
      • 10.1.2 External Fixators Overall Revenues (2000-2012)
    • 10.2 Trauma Fixation Overall Volume (2000-2012)
      • 10.2.1 Internal Fixators Overall Volume (2000-2012)
      • 10.2.2 External Fixators Overall Volume (2000-2012)
    • 10.3 Trauma Fixation Average Price (2000-2012)
      • 10.3.1 Internal Fixators Average Price (2000-2012)
      • 10.3.2 External Fixators Average Price (2000-2012)
    • 10.4 Trauma Fixation Distribution Share (2005-2006)
    • 10.5 Trauma Fixation Company Share (2005-2006)
  • 11 Orthopedic Accessories in China
    • 11.1 Orthopedic Accessories Overall Revenues (2000-2012)
      • 11.1.1 Bone Cements Overall Revenues (2000-2012)
      • 11.1.2 Cast Application and Removal System Overall Revenues (2000-2012)
    • 11.2 Orthopedic Accessories Category Volume (2000-2012)
      • 11.2.1 Cast Application and Removal System Overall Volume (2000-2012)
      • 11.2.2 Bone Cements Overall Volume (2000-2012)
    • 11.3 Orthopedic Accessories Average Price (2000-2012)
      • 11.3.1 Bone Cements Average Price (2000-2012)
      • 11.3.2 Cast Application and Removal System Average Price (2000-2012)
    • 11.4 Orthopedic Accessories Distribution Share (2005-2006)
    • 11.5 Orthopedic Accessories Company Share (2005-2006)
  • 12 DePuy, Inc. Company Profile
    • 12.1 Company Overview
    • 12.2 Business Overview
      • 12.2.1 Products:
      • 12.2.2 History
    • 12.3 Locations And Subsidiaries
    • 12.4 Financial Deals Landscape
      • 12.4.1 Precimed Acquires Chaumont Facility From Depuy
      • 12.4.2 Symmetry Medical Acquires Orthopedic Instrument Facility From DePuy
      • 12.4.3 DePuy Mitek Acquires Future Medical Systems
      • 12.4.4 DePuy Orthopaedics Acquires Hand Innovations
      • 12.4.5 Archus Orthopedics Raises $35 Million In Series C Financing
      • 12.4.6 DePuy Spine Acquires Assets From The Bright Group
      • 12.4.7 DePuy Spine To Acquire Assets From Disc-O-Tech Medical Technologies
    • 12.5 Recent Developments
      • 12.5.1 Mar 10, 2008: DePuy To Expand Cork Facility
    • 12.6 DePuy, Inc. Pipeline Products
      • 12.6.1 MOBILITY Total Ankle System
      • 12.6.2 Polydioxanone Suture (PDS)
      • 12.6.3 CHARITE Artificial Disc
      • 12.6.4 Delta Ceramax
      • 12.6.5 Proxima
      • 12.6.6 Cartilage Autograft Implantation System
      • 12.6.7 PFC Sigma RP-F Knee
      • 12.6.8 Compel
  • 13 Stryker Corporation Company Profile
    • 13.1 Company Overview
    • 13.2 Business Overview
      • 13.2.1 MedSurg Equipment
      • 13.2.2 Orthopaedic Implants
      • 13.2.3 Other
      • 13.2.4 Major Products and Services
      • 13.2.5 History
    • 13.3 Value Chain Analysis
      • 13.3.1 Manufacturing
      • 13.3.2 Product Development
      • 13.3.3 Sales and Marketing
    • 13.4 Financial and Operational Review
      • 13.4.1 Financial Statements
      • 13.4.2 Financial Ratios
      • 13.4.3 Share Holding Structure
    • 13.5 SWOT Analysis
      • 13.5.1 Stryker Corporation Strengths
      • 13.5.2 Stryker Corporation Weaknesses
      • 13.5.3 Stryker Corporation Opportunities
      • 13.5.4 Stryker Corporation Threats
    • 13.6 Locations And Subsidiaries
    • 13.7 Financial Deals Landscape
      • 13.7.1 Stryker Sells Physiotherapy Associates To Water Street Healthcare
      • 13.7.2 Stryker Acquires Sightline Technologies
      • 13.7.3 Stryker Acquires Plasmasol
      • 13.7.4 Stryker Signs An Agreement With Corin Group
      • 13.7.5 Stryker Acquires Etrauma
      • 13.7.6 Stryker Acquires SpineCore
      • 13.7.7 LifeCell Signs An Agreement With Stryker Howmedica Osteonics
    • 13.8 Recent Developments
      • 13.8.1 Jan 23, 2008: Stryker Declares Q4 2007 Results
      • 13.8.2 Dec 18, 2007: Stryker To Declare Q4 2007 Operating Results
      • 13.8.3 Dec 06, 2007: Stryker Increases Annual Dividend
      • 13.8.4 Oct 17, 2007: Stryker Declares Q3 2007 Results
      • 13.8.5 Jul 19, 2007: Stryker Declares Q2 2007 Results
      • 13.8.6 Apr 18, 2007: Stryker Declares Q1 2007 Results
      • 13.8.7 Mar 26, 2007: Stryker To Expand Sales In India
      • 13.8.8 Jan 25, 2007: Stryker Declares Year-End 2006 Results
      • 13.8.9 Jan 25, 2007: Stryker Declares Q4 2006 Results
      • 13.8.10 Dec 06, 2006: Stryker Declares Dividend
      • 13.8.11 Oct 17, 2006: Stryker Declares Q3 2006 Results
      • 13.8.12 Jul 27, 2006: Stryker Elects Additional Director
      • 13.8.13 Jul 20, 2006: Stryker Declares Q2 2006 Results
    • 13.9 Stryker Corporation Pipeline Products
      • 13.9.1 FlexiCore
      • 13.9.2 GEM OS2 Bone Graft Putty
      • 13.9.3 Aquarelle
      • 13.9.4 Cervicore Artificial Cervical Disc
      • 13.9.5 OP 1 Putty- transforaminal lumbar interbody fusions
      • 13.9.6 OP 1- cartilage regeneration
  • 14 Medtronic, Inc. Company Profile
    • 14.1 Company Overview
    • 14.2 Business Overview
      • 14.2.1 Cardiac Surgery
      • 14.2.2 CRDM
      • 14.2.3 Diabetes
      • 14.2.4 ENT
      • 14.2.5 Neurological
      • 14.2.6 Physio-Control
      • 14.2.7 Spinal and Navigation
      • 14.2.8 Vascular
      • 14.2.9 Major Products and Services
      • 14.2.10 History
    • 14.3 Value Chain Analysis
      • 14.3.1 Manufacturing
      • 14.3.2 Product Development
      • 14.3.3 Sales and Marketing
    • 14.4 SWOT Analysis
      • 14.4.1 Medtronic, Inc. Strengths
      • 14.4.2 Medtronic, Inc. Weaknesses
      • 14.4.3 Medtronic, Inc. Opportunities
      • 14.4.4 Medtronic, Inc. Threats
    • 14.5 Financial and Operational Review
      • 14.5.1 Financial Statements
      • 14.5.2 Financial Ratios
    • 14.6 Locations And Subsidiaries
    • 14.7 Financial Deals Landscape
      • 14.7.1 Medtronic Enters Into Licensing Agreement With Arbor Surgical Technologies
      • 14.7.2 REVA Medical Secures $42 Million In Financing
      • 14.7.3 CardioMEMS Secures $33 Million In Series E Financing
      • 14.7.4 Mitralign Secures $24 Million In Series C Financing
      • 14.7.5 Medtronic Acquires Kyphon
      • 14.7.6 Medtronic Acquires MRI Safety Patents From Biophan
      • 14.7.7 Bayer HealthCare Diabetes Care Signs An Agreement With Medtronic
      • 14.7.8 Alpine Acquires Neurodiagnostic Product Line From Medtronic
      • 14.7.9 Medtronic Signs An Agreement With Axon Systems
      • 14.7.10 Medtronic Acquires O-arm Imaging System Assets From Breakaway Imaging
      • 14.7.11 Alpine Biomed Acquires Gastroenterology Diagnostics Product Line From Medtronic
      • 14.7.12 Innerpulse Announces Closing Of $50 Million Series C Round
    • 14.8 Recent Developments
      • 14.8.1 Mar 19, 2008: FDA Calls Medtronic Drug Pump Warning Class I
      • 14.8.2 Mar 05, 2008: Recent Medical Device Recall Indicates Need For Patient Protections
      • 14.8.3 Mar 03, 2008: Medtronic Pays Akin Gump $140,000 To Lobby
      • 14.8.4 Mar 01, 2008: Medtronic And Other Device Makers Support Disclosure Of Payments To Doctors
      • 14.8.5 Feb 27, 2008: Medtronic Spends $1.7 Million On Lobbying In 2007
      • 14.8.6 Feb 27, 2008: Medtronic Announces First Human Use Of Its Bifurcation Stent
      • 14.8.7 Feb 26, 2008: Medtronic Says Sunshine Act Should Go Further
      • 14.8.8 Feb 22, 2008: Medtronic Elects New Board Member
      • 14.8.9 Feb 21, 2008: Medtronic Board Approves Quarterly Cash Dividend
      • 14.8.10 Feb 21, 2008: Medtronic Approves Cash Dividend
      • 14.8.11 Feb 20, 2008: US Supreme Court Shields Medical Device Manufacturers From Consumer Lawsuits
      • 14.8.12 Feb 19, 2008: Medtronic Declares Q3 Fiscal 2008 Results
      • 14.8.13 Feb 08, 2008: Medtronic To Declare Q3 Fiscal 2008 Results
      • 14.8.14 Feb 08, 2008: Medtronic to Announce Financial Results for Its Third Quarter
      • 14.8.15 Jan 28, 2008: Medtronic, Arbor Announce Exclusive Licensing Agreement
      • 14.8.16 Jan 10, 2008: Medtronic Foundation Announces New Grant Guidelines For Its HeartRescue Program
      • 14.8.17 Dec 21, 2007: Medtronic Resolves Marquis Defibrillator Lawsuits
      • 14.8.18 Dec 17, 2007: Medtronic And Weigao Announce Joint Venture In China
      • 14.8.19 Nov 19, 2007: Medtronic Declares Q2 Fiscal 2008 Results
      • 14.8.20 Nov 15, 2007: Brower Piven Announces Class Action Lawsuit Against Medtronic
      • 14.8.21 Nov 12, 2007: Medtronic To Declare Q2 Fiscal 2008 Results
      • 14.8.22 Oct 19, 2007: Medtronic Approves Cash Dividend
      • 14.8.23 Aug 23, 2007: Medtronic Elects New President And CEO
      • 14.8.24 Aug 23, 2007: Medtronic Declares Quarterly Dividend
      • 14.8.25 Aug 21, 2007: Medtronic Declares Q1 Fiscal 2008 Results
      • 14.8.26 Jun 22, 2007: Medtronic Elects New Directors
      • 14.8.27 Jun 22, 2007: Medtronic Declares Quarterly Dividend
      • 14.8.28 May 25, 2007: Biocompatibles Enters Agreement With Abbott
      • 14.8.29 May 22, 2007: Medtronic Declares Q4 Fiscal 2007 Results
      • 14.8.30 May 07, 2007: Biosense Announce Strategic Alliance With Medtronic
      • 14.8.31 Feb 20, 2007: Medtronic Declares Q3 Fiscal 2007 Results
      • 14.8.32 Jan 18, 2007: Medtronic Declares Quarterly Dividend
      • 14.8.33 Jan 18, 2007: Medtronic Elects New Board Member
      • 14.8.34 Jan 23, 2006: Edwards Lifesciences and Medtronic Settles Infringement Lawsuit
    • 14.9 Medtronic, Inc. Pipeline Products
      • 14.9.1 BRYAN Cervical Disc
      • 14.9.2 Endeavor Drug-Eluting Stent
      • 14.9.3 Medtronic Implantable Cardioverter Defibrillators
      • 14.9.4 EnRhythm MRI SureScan Pacing System
      • 14.9.5 DIAM Spinal Stabilization System
      • 14.9.6 Endurant Stent Graft System
      • 14.9.7 Talent Thoracic Stent Graft System
      • 14.9.8 PIVOTAL AAA
      • 14.9.9 Exponent RX Self-Expanding Carotid Stent
      • 14.9.10 GuardWire embolic protection system
      • 14.9.11 Deep Brain Stimulation (DBS) therapy
      • 14.9.12 Melody Transcatheter Pulmonary Valve
      • 14.9.13 Chronicle ICD
      • 14.9.14 Advantage Supra
      • 14.9.15 Pulmonic TCV
      • 14.9.16 Percutaneous AAA
      • 14.9.17 TGF Beta 1 Stent
      • 14.9.18 Cinched Mosaic
      • 14.9.19 LAA Occluder Band
      • 14.9.20 Prestige LP
      • 14.9.21 A-Mav
      • 14.9.22 Interceptor PLUS Coronary Filter System
      • 14.9.23 Sprint Quattro(Model 6944)
      • 14.9.24 Sprint Quattro(Model 6947)
      • 14.9.25 Valiant Thoracic Stent Graft
      • 14.9.26 Intercept Epilepsy Control System
      • 14.9.27 Bifurcation stent
      • 14.9.28 Single-coil Quattro lead
      • 14.9.29 Next Generation Insulin Pump
      • 14.9.30 Pre-filled Insulin Reservoirs
      • 14.9.31 Implantable Insulin Pump
  • 15 Zimmer Holdings, Inc. Company Profile
    • 15.1 Company Overview
    • 15.2 Business Overview
      • 15.2.1 Americas
      • 15.2.2 Asia Pacific
      • 15.2.3 Europe
      • 15.2.4 Major Products and Services
      • 15.2.5 History
    • 15.3 Value Chain Analysis
      • 15.3.1 Manufacturing
      • 15.3.2 Product Development
      • 15.3.3 Sales and Marketing
    • 15.4 SWOT Analysis
      • 15.4.1 Zimmer Holdings, Inc. Strengths
      • 15.4.2 Zimmer Holdings, Inc. Weaknesses
      • 15.4.3 Zimmer Holdings, Inc. Opportunities
      • 15.4.4 Zimmer Holdings, Inc. Threats
    • 15.5 Financial and Operational Review
      • 15.5.1 Financial Statements
      • 15.5.2 Financial Ratios
    • 15.6 Locations And Subsidiaries
    • 15.7 Financial Deals Landscape
      • 15.7.1 Zimmer Holdings Acquires ORTHOsoft
      • 15.7.2 Regeneration Technologies And Zimmer Holdings Enter Into Distribution Agreement
      • 15.7.3 Zimmer Holdings Acquires Endius
      • 15.7.4 Zimmer Holdings Signs Distribution Agreement With Brasseler USA
      • 15.7.5 Zimmer Holdings Expands Distribution Agreement With Heraeus Kulzer
      • 15.7.6 ISTO Technologies Completes $10.8 Million Financing
      • 15.7.7 Zimmer Holdings Enters Into An Agreement With Ohio Orthopedic Surgery Institute
      • 15.7.8 Zimmer Holdings Signs An Agreement With Heraeus Kulzer
      • 15.7.9 Zimmer Holdings Acquires Implex
    • 15.8 Recent Developments
      • 15.8.1 Apr 01, 2008: Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2008 Results
      • 15.8.2 Mar 17, 2008: Zimmer Holdings, Inc. Adds Robert Hagemann and Cecil Pickett to Board of Directors
      • 15.8.3 Mar 17, 2008: Zimmer Announces Board Changes
      • 15.8.4 Feb 05, 2008: Zimmer To Expand Manufacturing Network In Ireland
      • 15.8.5 Jan 29, 2008: Zimmer Declares Q4 2007 Results
      • 15.8.6 Nov 27, 2007: Zimmer Chiarman To Resign, McGoldrick To Serve As Non-Executive Chairman
      • 15.8.7 Oct 24, 2007: Zimmer Declares Q3 2007 Results
      • 15.8.8 Jul 25, 2007: Zimmer Declares Q2 2007 Results
      • 15.8.9 May 04, 2007: Zimmer To Expand Manufacturing And Distribution Facilities
      • 15.8.10 May 01, 2007: Zimmer Announces CEO And President
      • 15.8.11 Apr 25, 2007: Zimmer Reports Q1 2007 Results
      • 15.8.12 Feb 13, 2007: Zimmer Names Arthur Higgins To Board
      • 15.8.13 Jan 29, 2007: Zimmer Reports Q4 2006 Results
      • 15.8.14 Dec 13, 2006: Zimmer Issues 2007 Sales And Earnings Guidance
      • 15.8.15 Dec 12, 2006: Zimmer Announces Share Buyback Program
      • 15.8.16 Nov 20, 2006: Zimmer's President And CEO Plans To Retire
      • 15.8.17 Nov 15, 2006: Zimmer To Support Board Declassification
      • 15.8.18 Oct 25, 2006: Zimmer Reports Q3 2006 Results
      • 15.8.19 Sep 18, 2006: Zimmer Amends By-Laws
      • 15.8.20 Jul 27, 2006: Zimmer Enters Distribution Agreement With Brasseler
      • 15.8.21 Jul 26, 2006: Zimmer Reports Q2 2006 Results
      • 15.8.22 Jun 13, 2006: Zimmer, Burrell To Develop Information Campaign
    • 15.9 Zimmer Holdings, Inc. Pipeline Products
      • 15.9.1 Denovo ET
      • 15.9.2 Newcleus
      • 15.9.3 Dynesys System
      • 15.9.4 Durom Full Resurfacing Hip
      • 15.9.5 BRIGIT Bone Resection Instrument Guide
      • 15.9.6 Natural-Knee II High-Flex Gender
      • 15.9.7 NexGen LPS-Flex Mobile Knee
  • 16 Biomet, Inc. Company Profile
    • 16.1 Company Overview
    • 16.2 Business Overview
      • 16.2.1 Fixation Device Category
      • 16.2.2 Other Products Category
      • 16.2.3 Reconstructive Products Category
      • 16.2.4 Spinal Products Category
      • 16.2.5 Major Products and Services
      • 16.2.6 History
    • 16.3 Value Chain Analysis
      • 16.3.1 Manufacturing
      • 16.3.2 Product Development
      • 16.3.3 Sales and Marketing
    • 16.4 SWOT Analysis
      • 16.4.1 Biomet, Inc. Strengths
      • 16.4.2 Biomet, Inc. Weaknesses
      • 16.4.3 Biomet, Inc. Opportunities
      • 16.4.4 Biomet, Inc. Threats
    • 16.5 Financial and Operational Review
      • 16.5.1 Financial Statements
      • 16.5.2 Financial Ratios
      • 16.5.3 Share Holding Structure
    • 16.6 Locations And Subsidiaries
    • 16.7 Financial Deals Landscape
      • 16.7.1 Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts And TPG Acquires Biomet
      • 16.7.2 Biomet And Diamicron Enter Into Development And Distribution Agreement
      • 16.7.3 Biomet Acquires Interpore International
      • 16.7.4 Biomet Acquires Biomet-Merck From Merck
      • 16.7.5 Smith & Nephew Terminates Acquisition Of Biomet
    • 16.8 Recent Developments
      • 16.8.1 Feb 29, 2008: Biomet Appoints New President, Orthopedics Division
      • 16.8.2 Jan 10, 2008: Biomet Declares Q2 Fiscal 2008 Results
      • 16.8.3 Oct 15, 2007: Biomet Declares Q1 Fiscal 2008 Results
      • 16.8.4 Jul 09, 2007: Biomet Declares Q4 Fiscal 2007 Results
      • 16.8.5 May 21, 2007: Biomet And Massachusetts General Hospital Form Research Alliance
      • 16.8.6 May 14, 2007: Biomet Appoints New CFO
      • 16.8.7 Apr 13, 2007: NASDAQ Grants Continued Listing To Biomet
      • 16.8.8 Apr 04, 2007: Biomet Announces Senior Management Changes
      • 16.8.9 Mar 08, 2007: Biomet Introduces NanoTite Dental Implant Technology
      • 16.8.10 Feb 26, 2007: Biomet Appoints President And CEO
      • 16.8.11 Feb 05, 2007: Biomet Announces Licensing Agreement
      • 16.8.12 Dec 18, 2006: Biomet Announces Preliminary Unaudited Net Sales For Q2 2006
      • 16.8.13 Dec 18, 2006: Biomet Announces Delay In Q2 Results
      • 16.8.14 Sep 20, 2006: Biomet Announces Q1 2006 Results
      • 16.8.15 Aug 04, 2006: Biomet Retains Services Of Heidrick & Struggles And The McLoughlin Company
      • 16.8.16 Jul 12, 2006: Biomet Announces Senior Management Changes
      • 16.8.17 Jun 28, 2006: Biomet Declares Dividend
      • 16.8.18 Jun 28, 2006: Biomet Reports Q4 2006 Results
    • 16.9 Biomet, Inc. Pipeline Products
      • 16.9.1 EBI Polymer Reinforced Pro Osteon
      • 16.9.2 Rescue Cervical Disc
      • 16.9.3 Regain
      • 16.9.4 Min T Total Disc Replacement
      • 16.9.5 Cobalt MV (Medium Viscosity) Bone Cement
      • 16.9.6 OptiPac
      • 16.9.7 OptiLock Distal Femoral Plating System
      • 16.9.8 Distal Tibial Plating System
      • 16.9.9 VPC (Variable Pitch Compression) Screw System
      • 16.9.10 Cobalt V Bone Cement
      • 16.9.11 Allogenix Plus
      • 16.9.12 ReCap Total Hip Resurfacing System
  • 17 Regulation System
    • 17.1 Medical Equipment Approval Process
      • 17.1.1 Classification
      • 17.1.2 Registration and Conformity assessment
      • 17.1.3 China Compulsory Certificate (CCC Mark)
      • 17.1.4 Labeling and Packaging
      • 17.1.5 Registration Fee
      • 17.1.6 Registration Period
    • 17.2 Post Market Surveillance (PMS)
  • 18 Pricing and Reimbursement
  • 19 Distribution Structure
  • 20 APPENDIX
    • 20.1 Methodology
    • 20.2 Coverage
    • 20.3 Secondary Research
    • 20.4 Primary Research
    • 20.5 Models
    • 20.6 Forecasts
    • 20.7 Expert Panels
    • 20.8 Currency Conversion
    • 20.9 Contact Us
    • 20.10 Disclaimer